Anbio Biotechnology
NASDAQ:NNNN
Fundamental Analysis

Revenue & Expenses Breakdown
Anbio Biotechnology
Balance Sheet Decomposition
Anbio Biotechnology
Current Assets | 18.5m |
Cash & Short-Term Investments | 11.8m |
Receivables | 1.1m |
Other Current Assets | 5.7m |
Non-Current Assets | 387.5k |
Other Non-Current Assets | 387.5k |
Free Cash Flow Analysis
Anbio Biotechnology
Free Cash Flow |
Earnings Waterfall
Anbio Biotechnology
Revenue
|
8.2m
|
Cost of Revenue
|
-2.3m
|
Gross Profit
|
5.9m
|
Operating Expenses
|
-3.9m
|
Operating Income
|
2m
|
Other Expenses
|
377.4k
|
Net Income
|
2.4m
|
NNNN Profitability Score
Profitability Due Diligence
Anbio Biotechnology's profitability score is 70/100. The higher the profitability score, the more profitable the company is.
Score
Anbio Biotechnology's profitability score is 70/100. The higher the profitability score, the more profitable the company is.
NNNN Solvency Score
Solvency Due Diligence
Anbio Biotechnology's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Anbio Biotechnology's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NNNN Price Targets Summary
Anbio Biotechnology
Dividends
Current shareholder yield for NNNN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?